A nurse is assessing a client with panic disorder who is prescribed benzodiazepines. Which statement by the client indicates a need for further education?

Choice A rationale:

If the client reports a decrease in the frequency and severity of panic attacks, it indicates effective management of panic disorder. This outcome suggests that the treatment interventions are successfully reducing the occurrence and intensity of panic attacks, leading to improved overall well-being.

Choice B rationale:

While engaging in social activities and maintaining supportive relationships (choice B) is important for the client's mental health, it doesn't directly indicate the effectiveness of panic disorder management. The client might be socially active but still experiencing panic attacks.

Choice C rationale:

Demonstrating effective coping skills and positive self-talk (choice C) is certainly a positive outcome. However, this alone might not fully reflect the successful management of panic disorder. Effective coping skills are a part of the management plan, but the reduction in panic attack frequency is a more specific indicator of treatment effectiveness.

Choice D rationale:

Adhering to the prescribed treatment regimen and following up with appointments (choice D) is crucial for any medical condition, including panic disorder. However, this outcome doesn't directly measure the reduction in panic attacks, which is a more specific measure of successful management.

Choice A rationale:

Beta-blockers are not commonly used for the pharmacological treatment of panic disorder. While they are used for conditions like hypertension and certain heart conditions, they are not the primary choice for panic disorder. Panic disorder primarily involves disturbances in brain neurotransmitters, which beta-blockers do not directly target.

Choice B rationale:

Anticonvulsants are not the primary choice for treating panic disorder. While they may be used for other conditions such as epilepsy or bipolar disorder, their effectiveness in treating panic disorder is limited compared to other classes of medications like SSRIs.

Choice C rationale:

Selective serotonin reuptake inhibitors (SSRIs) are commonly used for the pharmacological treatment of panic disorder. Panic disorder often involves imbalances in serotonin, a neurotransmitter that plays a crucial role in mood regulation. SSRIs help increase serotonin levels in the brain by blocking its reuptake, thereby alleviating symptoms of panic and anxiety.

Choice D rationale:

Tricyclic antidepressants (TCAs) are sometimes used for panic disorder, but they are not the first-line treatment due to their potential side effects and safety concerns. SSRIs have largely replaced TCAs as the preferred choice due to their better tolerability and safety profile.